A Rapid Corneal Healing Microneedle for Efficient Ocular Drug Delivery

Hui Shi1, Jianhong Zhou1, Yuan Wang1

  • 1Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027, China.

Insights

A novel dissolving microneedle (MN) patch offers a minimally invasive treatment for fungal keratitis (FK). This Poly(D,L-lactide) and hyaluronic acid MN patch shows superior efficacy and faster healing compared to eye drops.

Area of Science:

  • Ophthalmology
  • Biomaterials Science
  • Drug Delivery Systems

Background:

  • Fungal keratitis (FK) poses a significant global health challenge, necessitating advanced ocular drug delivery methods.
  • Current treatments often lack optimal efficacy or involve invasive procedures.

Purpose of the Study:

  • To develop and evaluate a minimally invasive, dissolving microneedle (MN)-array patch for treating FK.
  • To optimize MN patch properties for enhanced corneal drug delivery and therapeutic outcomes.

Main Methods:

  • Fabrication of dissolving MN patches using Poly(D,L-lactide) (PLA) and hyaluronic acid (HA).
  • Optimization of PLA concentration to achieve desired MN properties and corneal penetration.
  • Evaluation of MN patch performance in a rabbit FK model, comparing it to eye drops and intrastromal injection.

Main Results:

  • Optimized 30% PLA-HA MN patches demonstrated reversible corneal penetration with minimal irritation and rapid healing (<12 h).
  • MN patches increased drug residence time in the conjunctival sac by 2.5 hours, enhancing bioavailability.
  • Topical MN patch application showed superior therapeutic effects over conventional eye drops and comparable efficacy to intrastromal injections in a rabbit FK model.

Conclusions:

  • The PLA-HA dissolving MN patch serves as a highly effective ocular drug delivery system for FK treatment.
  • This minimally invasive approach offers rapid corneal healing and improved drug bioavailability, presenting a promising alternative to current FK therapies.
  • The MN patch technology holds potential as a cost-effective household and clinical solution for fungal keratitis.